```html

Quinine‑Induced Hemolysis in People With G6PD Deficiency

Overview

Quinine‑induced hemolysis is a form of oxidative hemolytic anemia that occurs when individuals who have a genetic deficiency of the enzyme glucose‑6‑phosphate dehydrogenase (G6PD) are exposed to quinine, a medication historically used to treat malaria and leg cramps. The lack of functional G6PD impairs red‑blood‑cell (RBC) protection against oxidative stress, so quinine can trigger rapid destruction of RBCs (hemolysis).

• Who it affects: Anyone with G6PD deficiency—including men, women, and children—may develop hemolysis after taking quinine. Because G6PD is X‑linked, the condition is more common in males (≈1 in 13) but can affect females who are homozygous or heterozygous carriers.
• Global prevalence: An estimated 400 million people worldwide have G6PD deficiency, making it the most common enzymatic disorder of RBCs. Highest rates are seen in sub‑Saharan Africa, the Mediterranean, the Middle East, and Southeast Asia (5–20 % of the population in those regions).<sup>WHO</sup>
• Why quinine matters: Although less frequently prescribed today, quinine is still found in over‑the‑counter “night‑time” leg‑cramp remedies, in some tonic water brands (≈83 mg/L), and as a component of certain antimalarial regimens.<sup>CDC</sup>

Symptoms

Symptoms reflect the degree of hemolysis and may appear within hours to a few days after quinine exposure. The classic triad is:

• Fatigue & weakness – due to anemia.
• Jaundice – yellowing of the skin and sclera from elevated bilirubin.
• Dark urine – hemoglobinuria gives urine a tea‑colored appearance.

Full Symptom List

<

General	Rapid onset of tiredness, dizziness, or shortness of breath, especially on exertion.
Skin & Eyes	Yellowing of eyes, palms, or soles; pallor of lips and nail beds.
Urinary	Tea‑ or cola‑colored urine; reduced urine output if severe.
Gastrointestinal	Nausea, vomiting, abdominal pain, especially in the upper right quadrant (hepatomegaly).
Cardiovascular	Rapid heartbeat (tachycardia), low blood pressure if anemia is profound.
Neurologic	Headache, confusion, or fainting (syncope) secondary to low oxygen delivery.
Other	Back pain (renal colic from hemoglobin casts), fever (often from concomitant infection).

Causes and Risk Factors

Underlying Mechanism

G6PD is essential for the pentose‑phosphate pathway, which generates NADPH. NADPH maintains glutathione in a reduced state, protecting RBC membranes from oxidative damage. Quinine and its metabolites generate reactive oxygen species; without sufficient NADPH, RBCs cannot counteract the stress, leading to membrane lipid peroxidation and hemolysis.

Key Triggers

• Therapeutic quinine (malaria prophylaxis/treatment, nocturnal leg‑cramp pills).
• Ingestion of quinine‑containing beverages (tonic water, certain “energy” drinks).
• Concurrent use of other oxidative drugs (e.g., sulfonamides, dapsone, primaquine, nitrofurantoin).

Who Is at Higher Risk?

• Genetic variants: Class I–III G6PD mutations (severe deficiency) carry the highest risk. The Mediterranean (G6PD‑Mediterranean) and African A‑ variants are especially vulnerable.<sup>NIH</sup>
• Age: Infants and young children may develop severe hemolysis more quickly because their total RBC mass is smaller.
• Pregnancy: Physiologic anemia and increased oxidative stress make pregnant women more susceptible.
• Co‑existing illnesses: Infections (especially viral), liver disease, or renal impairment can potentiate hemolysis.
• Geography & ethnicity: Populations from malaria‑endemic regions have higher carrier rates.

Diagnosis

Prompt recognition is essential because hemolysis can progress rapidly. Diagnosis combines clinical suspicion with laboratory testing.

Initial Clinical Evaluation

• History of quinine exposure within the past 24‑72 hours.
• Physical exam noting pallor, jaundice, splenomegaly, and dark urine.

Laboratory Tests

1. Complete blood count (CBC): Shows a rapid drop in hemoglobin/hematocrit; often a reticulocytosis (↑ reticulocytes) as bone marrow tries to compensate.
2. Lactate dehydrogenase (LDH): Elevated due to RBC breakdown.
3. Haptoglobin: Decreased (consumed when binding free hemoglobin).
4. Unconjugated bilirubin: Elevated, leading to jaundice.
5. Urine dipstick for blood: Positive for “blood” without red cells on microscopy (hemoglobinuria).
6. G6PD enzyme assay: Quantitative spectrophotometric measurement; ideally done after hemolysis subsides because reticulocytes have higher G6PD activity and can give a false‑normal result.
7. Genetic testing: PCR‑based panels identify specific G6PD variants – useful for family counseling.

Differential Diagnosis

Other causes of acute hemolysis that must be ruled out include autoimmune hemolytic anemia, sickle cell crisis, malaria infection, and drug‑induced hemolysis from agents other than quinine.

Treatment Options

Management is primarily supportive; the cornerstone is removal of the offending agent and careful monitoring.

Immediate Steps

• Stop quinine exposure: Discontinue any quinine‑containing medication, tonic water, or supplement.
• Hydration: Intravenous isotonic saline (e.g., 0.9% NaCl) to maintain renal perfusion and facilitate clearance of hemoglobin.

Medical Therapies

• Blood transfusion: Indicated if hemoglobin falls < 7 g/dL (or < 8 g/dL in patients with cardiovascular disease) or if symptomatic anemia persists.
• Erythropoiesis‑stimulating agents (ESAs): Rarely used; considered only in prolonged hemolysis with inadequate marrow response.
• Folic acid supplementation: 1 mg daily to support RBC production.
• Corticosteroids: Generally not effective for G6PD‑related hemolysis; reserved only if an autoimmune process is also suspected.

Procedures

• Renal monitoring: Hourly urine output measurement; consider renal ultrasound if hemoglobin casts cause obstruction.
• Dialysis: In severe acute kidney injury (AKI) secondary to hemoglobinuria, renal replacement therapy may be required.

Follow‑up Care

• Repeat CBC and hemolysis labs every 24‑48 hours until stable.
• Educate patient and family about avoiding quinine and other oxidative drugs.

Living with Quinine‑Induced Hemolysis (G6PD Deficiency)

While quinine is a well‑known trigger, many other substances can cause hemolysis in G6PD‑deficient individuals. Lifestyle adjustments focus on awareness and avoidance.

Practical Daily Management

• Carry a medical alert card or bracelet that states “G6PD deficiency – avoid quinine, sulfa drugs, and other oxidants.”
• Read medication labels carefully—look for quinine, primaquine, dapsone, nitrofurantoin, chloramphenicol, and certain antiretrovirals.
• Check food and beverage ingredients—tonic water, certain bitter lemon sodas, and some herbal supplements may contain quinine.
• Maintain adequate hydration (≈2 L/day) to keep kidneys flushing hemoglobin breakdown products.
• Take folic acid daily (1 mg) to aid RBC regeneration.
• Vaccinations—especially influenza and pneumococcal vaccines, because infections can precipitate oxidative stress.
• Family screening—relatives may also carry the deficiency; encourage testing.

When to Contact Your Doctor

• New onset of dark urine or yellowing of eyes.
• Unexplained fatigue, dizziness, or shortness of breath.
• Any prescription or over‑the‑counter drug that you suspect may contain quinine.

Prevention

Preventing hemolysis is largely about avoiding known oxidant triggers.

1. Medication safety:
   • Ask your pharmacist or prescriber for a “G6PD‑safe” medication list.
   • Avoid quinine, primaquine, sulfonamides (e.g., trimethoprim‑sulfamethoxazole), dapsone, nitrofurantoin, and high‑dose vitamin C (> 2 g/day).
2. Food & beverage vigilance:
   • Read labels on tonic water, “energy” drinks, and herbal teas.
   • Limit fava beans, “lima” beans, and certain legumes known to provoke hemolysis in rare cases.
3. Travel precautions:
   • If traveling to malaria‑endemic areas, discuss alternative prophylaxis (e.g., atovaquone‑proguanil) with your clinician.
4. Routine health checks: Annual CBC and hemolysis panel if you have a history of severe episodes.

Complications

If hemolysis is severe or untreated, several serious complications can develop.

• Acute kidney injury (AKI): Hemoglobin casts obstruct tubules, leading to renal failure in up to 10–15 % of severe cases.<sup>Cleveland Clinic</sup>
• Severe anemia: May cause cardiac strain, heart failure, or ischemic events, especially in patients with pre‑existing heart disease.
• Hyperbilirubinemia & gallstones: Chronic hemolysis raises bilirubin, promoting pigment gallstone formation.
• Jaundice‑related kernicterus: Rare in adults but possible in newborns with high bilirubin levels.
• Hypersplenism: Persistent splenic sequestration of damaged RBCs can exacerbate anemia.

When to Seek Emergency Care

Key References

• World Health Organization. G6PD Deficiency Fact Sheet. 2023. https://www.who.int
• Centers for Disease Control and Prevention. Malaria Treatment Guidelines. 2022. https://www.cdc.gov
• Mayo Clinic. G6PD deficiency. Updated 2024. https://www.mayoclinic.org
• Cleveland Clinic. Acute Kidney Injury. 2024. https://my.clevelandclinic.org
• NIH National Library of Medicine. “Glucose‑6‑Phosphate Dehydrogenase Deficiency.” 2022. https://www.ncbi.nlm.nih.gov

```